Category: Replacement Heart Valves
Heart Valves
California medical device maker Claret Medical's embolic protection technology captures debris traveling toward the brain in 30 of the 40 clinical trial patients undergoing transcatheter aortic valve implantation procedures.
Claret Medical's Montage Dual Filter system is poised to become a staple of transcatheter aortic valve implantation procedures if the company has anything to say about it.
In an original manuscript published by researcher Dr. Nicolas Van Mieghem he concluded that the Montage device captured "embolic debris" traveling to the brain in 75% of patients undergoing TAVI.
Direct Flow Medical wins FDA approval for a U.S. trial of its new transcatheter aortic valve implant.
The FDA granted Direct Flow Medical an investigational device exemption for its transcatheter aortic valve implant, with the medical device company announcing enrollment in its Salus feasibility trial.
Repairing failed biological heart valves with transcatheter aortic valve implants showed good short-term results, according to a study presented last week at the American Assn. for Thoracic Surgery’s annual meeting.
The short-term results of minimally invasive transcatheter valve-in-valve implantation to treat failed biological heart valve protheses are "excellent," but patients must be closely monitored due to some notable cases of suboptimal systolic-valve performance, according to early data from a multi-center trial.
A $750 million share repurchasing plan, and CEO Mike Mussallem's plan to buy $5 million shares on his own, sends Edwards Lifesciences stock up nearly 7% today.
Edwards Lifesciences (NYSE:EW) said it plans to buy back another $750 million worth of its own stock during the 2nd quarter, with CEO Michael Mussallem buying another $5 million worth on his own.
New Jersey governor Chris Christie's revelation this week that he had LAP-BAND procedure for weight loss hightlights the power of celebrity endorsements for medical procedures
When the New York Post broke the story this week that New Jersey governor and presidential hopeful Chris Christie had underwent weight loss surgery using the LAP-BAND in February some on Wall Street bemoaned the rotund politicians timing.
Medtronic's CoreValve subsidiary asks the U.S. Supreme Court to consider its appeal of a lower court's decision to uphold a $74 million verdict in favor of Edwards Lifesciences and its Sapien heart valve.
A patent extension from the U.S. Patent & Trademark Office for its Sapien heart valve prompts Edwards Lifesciences to ask for additional damages in its infringement win over Medtronic's rival CoreValve implant.
